查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
欧洲透皮给药系统市场预测至 2030 年 - 区域分析 - 按类型、应用和配销通路
市场调查报告书
商品编码
1510745

欧洲透皮给药系统市场预测至 2030 年 - 区域分析 - 按类型、应用和配销通路

Europe Transdermal Drug Delivery System Market Forecast to 2030 - Regional Analysis - by Type, Application, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 120 Pages | 订单完成后即时交付

价格

欧洲透皮给药系统市场预计将从2022年的104.3386亿美元成长到2030年的144.2286亿美元。

对非侵入性给药设备不断增长的需求推动了欧洲透皮给药系统市场

传统的药物传递技术，例如肌肉内、静脉注射和直肠给药，并不受到某些患者群体的青睐，主要是因为它们带来的疼痛和复杂性。随着医学科学和明确的药物传输技术的进步，非侵入性药物传输系统现在将与传统的注射给药途径竞争。非侵入性给药系统包括口服给药；专题；透皮主动（设备辅助增强渗透）和透皮被动；以及吸入药物产生的经眼膜、经由黏膜及肺泡膜。透皮药物递送在许多方面都优于口服给药途径。特别是，它避开了肝臟的首过机制，否则肝臟会衝动地代谢药物。

此外，透皮给药不像皮下注射那么痛苦，而且这种途径不会产生危险的医疗废物，也不会因针头重复使用而造成疾病传播的风险，这在发展中国家和欠发达国家尤其常见。此外，非侵入性透皮给药系统简化了给药方案，并且可以自行给药。当非侵入性给药时，由于疼痛很少或没有疼痛，患者的依从性要高得多。因此，该途径被认为是优选的药物递送模式。此外，由于患者可自行给药，非侵入性给药系统可显着降低临床使用成本。因此，与经皮药物递送系统促进的非侵入性药物递送相关的优势推动了市场的成长。

欧洲透皮给药系统市场概况

欧洲透皮给药系统市场分为英国、法国、德国、西班牙、义大利和欧洲其他地区。 2022年，德国在欧洲透皮给药系统市场中占最大份额。由于该地区对疼痛管理的需求不断增长以及心血管疾病的盛行率不断上升，预计该市场将大幅增长。心臟衰竭、心肌梗塞、冠状动脉心臟病和发炎性心臟病等心血管疾病是该地区最广泛的健康问题。德国以其先进的技术而闻名，这些技术帮助该国在医疗和保健领域处于领先地位。根据美国国家生物技术资讯中心 (NCBI) 2021 年发表的一项研究，东德的心血管疾病盛行率往往较高。近年来，该国也见证了市场参与者不断增加的创新。 2023 年 5 月，BioNxt Solutions Inc. 获得政府批准，对旨在治疗帕金森氏症的透皮罗替高汀贴片进行药物吸收比较研究。该公司在北美和欧洲设有研发业务，营运重点在德国，目前正在接受欧洲市场医疗产品的监管批准和商业化。

2019 年 3 月，LTS Lohmann Therapie-Systeme AG 和 LEO Pharma A/S 共同启动了局部皮内治疗牛皮癣的微阵列贴片的临床试验。

德国也是出口医疗保健产品和服务的主要国家之一。此外，技术进步资产也为品质、安全性和可靠性设定了国际标准。此外，所有健康和医疗领域的德国製造商和服务提供者透过提供医疗保健创新吸引了外国客户和合作伙伴。透皮贴片的此类发展推动了德国透皮给药系统市场的成长。

欧洲透皮给药系统市场收入及 2030 年预测（百万美元）

欧洲透皮给药系统市场细分

欧洲透皮给药系统市场按类型、应用、配销通路和国家细分。

根据类型，欧洲透皮给药系统市场分为透皮贴片、透皮凝胶、透皮喷雾等。 2022年，透皮凝胶细分市场将占据欧洲透皮给药系统市场的最大份额。剂。

从应用来看，欧洲透皮给药系统市场分为心血管疾病、中枢神经系统疾病、疼痛管理、荷尔蒙应用和其他应用。到2022年，疼痛管理领域在欧洲透皮给药系统市场中占据最大份额。荷尔蒙应用进一步细分为透皮雌激素和黄体素治疗以及睪固酮替代疗法。

依配销通路，欧洲透皮给药系统市场分为医院药局、零售药局、线上药局等。 2022年，医院药局部门在欧洲透皮给药系统市场中占最大份额。

根据国家/地区，欧洲透皮给药系统市场分为英国、法国、德国、西班牙、义大利和欧洲其他地区。 2022年，德国在欧洲透皮给药系统市场占据主导地位。

勃林格殷格翰国际有限公司、葛兰素史克公司、久光製药有限公司、强生公司、Lavipharm SA、绿叶製药集团有限公司、诺华公司、UCB SA 和Viatris Inc 是欧洲透皮给药系统市场的一些领先公司。

目录

第 1 章：简介

第 2 章：执行摘要

  • 重要见解

第 3 章：研究方法

  • 覆盖范围
  • 二次研究
  • 初步研究

第 4 章：欧洲透皮给药系统市场 - 主要产业动态

  • 市场驱动因素
    • 慢性病盛行率增加
    • 对非侵入性给药设备的需求不断增长
    • 自我用药需求旺盛
  • 市场限制
    • 经皮给药系统的不良反应与召回
  • 市场机会
    • 智慧补丁和 3D 列印补丁的进步
  • 未来的趋势
    • 製造商的策略倡议
  • 影响分析

第 5 章：透皮给药系统市场 - 欧洲市场分析

  • 欧洲透皮给药系统市场收入，2022 - 2030

第 6 章：欧洲透皮给药系统市场 - 收入和 2030 年预测 - 按类型

  • 概述
  • 欧洲透皮给药系统市场收入份额，按类型 2022 年和 2030 年 (%)
  • 透皮贴剂
  • 透皮凝胶
  • 透皮喷剂
  • 其他的

第 7 章：欧洲透皮给药系统市场 - 收入和 2030 年预测 - 按应用

  • 概述
  • 2022 年及 2030 年欧洲经皮给药系统市场收入份额，依应用分类 (%)
  • 心血管疾病
  • 中枢神经系统疾病
  • 疼痛管理
  • 荷尔蒙应用
  • 其他应用

第 8 章：欧洲透皮给药系统市场 - 收入和 2030 年预测 - 按配销通路

  • 概述
  • 2022 年及 2030 年欧洲透皮给药系统市场收入份额，依配销通路划分 (%)
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他的

第 9 章：欧洲透皮给药系统市场 - 收入与 2030 年预测 - 国家分析

  • 德国
  • 法国
  • 英国
  • 义大利
  • 西班牙
  • 欧洲其他地区

第 10 章：透皮给药系统市场产业格局

  • 概述
  • 透皮给药系统市场的成长策略
  • 无机成长策略
    • 概述
  • 有机成长策略
    • 概述

第 11 章：公司简介

  • Novartis AG
  • Johnson & Johnson
  • GSK Plc
  • Viatris Inc
  • Boehringer Ingelheim International GmbH
  • Hisamitsu Pharmaceutical Co Inc
  • Luye Pharma Group Ltd
  • Lavipharm SA
  • UCB SA

第 12 章：附录

Product Code: TIPRE00013279

The Europe transdermal drug delivery system market is expected to grow from US$ 10,433.86 million in 2022 to US$ 14,422.86 million by 2030. It is estimated to register a CAGR of 4.1% from 2022 to 2030.

Growing Demand for Noninvasive Drug Delivery Devices Fuels Europe Transdermal Drug Delivery System Market

Traditional drug delivery techniques such as intramuscular, intravenous, and rectal drug administration are not preferred by certain patient populations mainly due to the pain and complexities associated with them. With the improvements in medical science and definite drug delivery technologies, noninvasive drug delivery systems are now set to compete with the traditional method of injectable route of drug administration. The noninvasive drug delivery systems include drug delivery via oral; topical; transdermal-active (device-aided enhanced penetration) and transdermal-passive; and transocular membrane, transmucosal membrane, and alveolar membrane from inhaled medication. Transdermal drug delivery is advantageous in many ways over the oral route of administration. In particular, it evades the first-pass mechanism of the liver, which can otherwise impulsively metabolize drugs.

Further, transdermal delivery is not as painful as hypodermic injections, and this route leads to no dangerous medical waste and poses no risk of disease transmission by needle reuse, which is especially common in developing and under-developed countries. In addition, a noninvasive transdermal drug delivery system has simplified dosing schedules, and the drugs can be self-administered. Patient compliance is much higher when drugs are administrated noninvasively due to low or no pain involved. Therefore, this route is considered a preferred mode of drug delivery. Moreover, a non-invasive drug delivery system can significantly reduce the cost of clinical use because of the self-administration of the drugs by the patients. Thus, the advantages associated with a noninvasive drug delivery facilitated by transdermal drug delivery systems drive the market growth.

Europe Transdermal Drug Delivery System Market Overview

The Europe transdermal drug delivery system market is segmented into the UK, France, Germany, Spain, Italy, and the Rest of Europe. In 2022, the Germany held the largest share of the Europe transdermal drug delivery system market. The market is expected to grow significantly owing to the growing need for pain management and the increasing prevalence of cardiovascular diseases in the region. Cardiovascular diseases such as heart failure, myocardial infarction, coronary cardiac disease, and inflammatory heart disease account for the broadest health problems in the region. Germany is known for its advancement in technology that helps lead the country to the forefront in the medical and healthcare sectors. According to a study published in 2021 in the National Center for Biotechnology Information (NCBI), cardiovascular disease prevalence is often higher in East Germany. The country has also witnessed increasing innovations through market players in recent years. In May 2023, BioNxt Solutions Inc. received government approval to proceed with a comparative drug absorption study for a transdermal Rotigotine patch designed to treat Parkinson's disease. The company has R&D operations in North America and Europe, with an operational focus in Germany, and is currently undergoing regulatory approval and commercialization of medical products for European markets.

In March 2019, LTS Lohmann Therapie-Systeme AG and LEO Pharma A/S together started a clinical trial of microarray patches for the local intradermal treatment of psoriasis.

Germany is also among the primary countries that export healthcare products and services. In addition, the asset of technological advancement has set international standards for quality, safety, and reliability. Moreover, the German manufacturers and service providers in all health and medical segments fascinate foreign customers and partners by delivering healthcare innovation. Such developments in transdermal patches fuel the growth of the transdermal drug delivery system market in Germany.

Europe Transdermal Drug Delivery System Market Revenue and Forecast to 2030 (US$ Million)

Europe Transdermal Drug Delivery System Market Segmentation

The Europe transdermal drug delivery system market is segmented into type, application, distribution channel, and country.

Based on type, the Europe transdermal drug delivery system market is segmented into transdermal patches, transdermal gel, transdermal sprays, and others. The transdermal gel segment held the largest share of the Europe transdermal drug delivery system market in 2022. The transdermal patches is further sub segmented into drug-in-adhesive patches, matrix patches, reservoir membrane patches, and vapor patches.

In terms of application, the Europe transdermal drug delivery system market is categorized into cardiovascular diseases, central nervous system disorders, pain management, hormonal applications, and other applications. The pain management segment held the largest share of the Europe transdermal drug delivery system market in 2022. The pain management is further sub segmented into opioid and non-opioid. The hormonal applications is further sub segmented into transdermal estrogen & progesterone therapy and testosterone replacement.

By distribution channel, the Europe transdermal drug delivery system market is segmented into hospitals pharmacies, retail pharmacies, online pharmacies, and others. The hospitals pharmacies segment held the largest share of the Europe transdermal drug delivery system market in 2022.

Based on country, the Europe transdermal drug delivery system market is categorized into the UK, France, Germany, Spain, Italy, and the Rest of Europe. Germany dominated the Europe transdermal drug delivery system market in 2022.

Boehringer Ingelheim International GmbH, GSK Plc, Hisamitsu Pharmaceutical Co Inc, Johnson & Johnson, Lavipharm SA, Luye Pharma Group Ltd, Novartis AG, UCB SA, and Viatris Inc are some of the leading companies operating in the Europe transdermal drug delivery system market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Europe Transdermal Drug Delivery System Market - Key Industry Dynamics

  • 4.1 Market Drivers
    • 4.1.1 Increasing Prevalence of Chronic Diseases
    • 4.1.2 Growing Demand for Noninvasive Drug Delivery Devices
    • 4.1.3 High Demand for Self-Administration of Drugs
  • 4.2 Market Restraints
    • 4.2.1 Adverse Effects and Recall of Transdermal Drug Delivery Systems
  • 4.3 Market Opportunities
    • 4.3.1 Advancements in Smart Patches and 3D-Printed Patches
  • 4.4 Future Trends
    • 4.4.1 Strategic Initiatives by Manufacturers
  • 4.5 Impact Analysis

5. Transdermal Drug Delivery System Market - Europe Market Analysis

  • 5.1 Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2022 - 2030

6. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Type

  • 6.1 Overview
  • 6.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • 6.3 Transdermal Patches
    • 6.3.1 Overview
    • 6.3.2 Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.1 Drug-in-Adhesive Patches
        • 6.3.2.1.1 Overview
        • 6.3.2.1.2 Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.2 Matrix Patches
        • 6.3.2.2.1 Overview
        • 6.3.2.2.2 Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.3 Reservoir Membrane Patches
        • 6.3.2.3.1 Overview
        • 6.3.2.3.2 Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 6.3.2.4 Vapor Patches
        • 6.3.2.4.1 Overview
        • 6.3.2.4.2 Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.4 Transdermal Gels
    • 6.4.1 Overview
    • 6.4.2 Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.5 Transdermal Sprays
    • 6.5.1 Overview
    • 6.5.2 Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 6.6 Others
    • 6.6.1 Overview
    • 6.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

7. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Application

  • 7.1 Overview
  • 7.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • 7.3 Cardiovascular Diseases
    • 7.3.1 Overview
    • 7.3.2 Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Central Nervous System Disorders
    • 7.4.1 Overview
    • 7.4.2 Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Pain Management
    • 7.5.1 Overview
    • 7.5.2 Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.1 Opioid
        • 7.5.2.1.1 Overview
        • 7.5.2.1.2 Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.5.2.2 Non-Opioid
        • 7.5.2.2.1 Overview
        • 7.5.2.2.2 Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.6 Hormonal Applications
    • 7.6.1 Overview
    • 7.6.2 Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.1 Transdermal Estrogen & Progesterone Therapy
        • 7.6.2.1.1 Overview
        • 7.6.2.1.2 Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
      • 7.6.2.2 Testosterone Replacement
        • 7.6.2.2.1 Overview
        • 7.6.2.2.2 Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.7 Other Application
    • 7.7.1 Overview
    • 7.7.2 Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

8. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - by Distribution Channel

  • 8.1 Overview
  • 8.2 Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • 8.3 Hospital Pharmacies
    • 8.3.1 Overview
    • 8.3.2 Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Retail Pharmacies
    • 8.4.1 Overview
    • 8.4.2 Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Online Pharmacies
    • 8.5.1 Overview
    • 8.5.2 Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)

9. Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 - Country Analysis

  • 9.1 Europe Transdermal Drug Delivery System Market
    • 9.1.1 Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
      • 9.1.1.1 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.1 Overview
        • 9.1.1.1.2 Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.1.3 Germany: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.3.1 Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.1.4 Germany: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.1 Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.4.2 Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.1.5 Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.1 Overview
        • 9.1.1.2.2 France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.2.3 France: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.3.1 France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.2.4 France: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.1 France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.4.2 France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.2.5 France: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.3 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.1 Overview
        • 9.1.1.3.2 UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.3.3 UK: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.3.1 UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.3.4 UK: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.1 UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.4.2 UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.3.5 UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.4 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.1 Overview
        • 9.1.1.4.2 Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.4.3 Italy: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.3.1 Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.4.4 Italy: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.1 Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.4.2 Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.4.5 Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.5 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.1 Overview
        • 9.1.1.5.2 Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.5.3 Spain: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.3.1 Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.5.4 Spain: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.1 Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.4.2 Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.5.5 Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)
      • 9.1.1.6 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.1 Overview
        • 9.1.1.6.2 Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
        • 9.1.1.6.3 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.3.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type, 2020-2030 (US$ Million)
        • 9.1.1.6.4 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.1 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.4.2 Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application, 2020-2030 (US$ Million)
        • 9.1.1.6.5 Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel, 2020-2030 (US$ Million)

10. Transdermal Drug Delivery System Market Industry Landscape

  • 10.1 Overview
  • 10.2 Growth Strategies in the Transdermal Drug Delivery System Market
  • 10.3 Inorganic Growth Strategies
    • 10.3.1 Overview
  • 10.4 Organic Growth Strategies
    • 10.4.1 Overview

11. Company Profiles

  • 11.1 Novartis AG
    • 11.1.1 Key Facts
    • 11.1.2 Business Description
    • 11.1.3 Products and Services
    • 11.1.4 Financial Overview
    • 11.1.5 SWOT Analysis
    • 11.1.6 Key Developments
  • 11.2 Johnson & Johnson
    • 11.2.1 Key Facts
    • 11.2.2 Business Description
    • 11.2.3 Products and Services
    • 11.2.4 Financial Overview
    • 11.2.5 SWOT Analysis
    • 11.2.6 Key Developments
  • 11.3 GSK Plc
    • 11.3.1 Key Facts
    • 11.3.2 Business Description
    • 11.3.3 Products and Services
    • 11.3.4 Financial Overview
    • 11.3.5 SWOT Analysis
    • 11.3.6 Key Developments
  • 11.4 Viatris Inc
    • 11.4.1 Key Facts
    • 11.4.2 Business Description
    • 11.4.3 Products and Services
    • 11.4.4 Financial Overview
    • 11.4.5 SWOT Analysis
    • 11.4.6 Key Developments
  • 11.5 Boehringer Ingelheim International GmbH
    • 11.5.1 Key Facts
    • 11.5.2 Business Description
    • 11.5.3 Products and Services
    • 11.5.4 Financial Overview
    • 11.5.5 SWOT Analysis
    • 11.5.6 Key Developments
  • 11.6 Hisamitsu Pharmaceutical Co Inc
    • 11.6.1 Key Facts
    • 11.6.2 Business Description
    • 11.6.3 Products and Services
    • 11.6.4 Financial Overview
    • 11.6.5 SWOT Analysis
    • 11.6.6 Key Developments
  • 11.7 Luye Pharma Group Ltd
    • 11.7.1 Key Facts
    • 11.7.2 Business Description
    • 11.7.3 Products and Services
    • 11.7.4 Financial Overview
    • 11.7.5 SWOT Analysis
    • 11.7.6 Key Developments
  • 11.8 Lavipharm SA
    • 11.8.1 Key Facts
    • 11.8.2 Business Description
    • 11.8.3 Products and Services
    • 11.8.4 Financial Overview
    • 11.8.5 SWOT Analysis
    • 11.8.6 Key Developments
  • 11.9 UCB SA
    • 11.9.1 Key Facts
    • 11.9.2 Business Description
    • 11.9.3 Products and Services
    • 11.9.4 Financial Overview
    • 11.9.5 SWOT Analysis
    • 11.9.6 Key Developments

12. Appendix

  • 12.1 About Us
  • 12.2 Glossary of Terms

List Of Tables

  • Table 1. Europe Transdermal Drug Delivery System Market Segmentation
  • Table 2. Germany: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 3. Germany: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 4. Germany: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 5. Germany: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 6. Germany: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 7. Germany: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 8. France: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 9. France: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 10. France: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 11. France: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 12. France: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 13. France: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 14. UK: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 15. UK: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 16. UK: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 17. UK: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 18. UK: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 19. UK: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 20. Italy: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 21. Italy: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 22. Italy: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 23. Italy: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 24. Italy: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 25. Italy: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 26. Spain: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 27. Spain: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 28. Spain: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 29. Spain: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 30. Spain: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 31. Spain: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 32. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 33. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Transdermal Patches by Type - Revenue and Forecast to 2030 (US$ Million)
  • Table 34. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 35. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Pain Management by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 36. Rest of Europe: Europe Transdermal Drug Delivery System Market, For Hormonal Applications by Application - Revenue and Forecast to 2030 (US$ Million)
  • Table 37. Rest of Europe: Europe Transdermal Drug Delivery System Market, by Distribution Channel - Revenue and Forecast to 2030 (US$ Million)
  • Table 38. Recent Inorganic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 39. Recent Organic Growth Strategies in the Transdermal Drug Delivery System Market
  • Table 40. Glossary of Terms, Europe Transdermal Drug Delivery System Market

List Of Figures

  • Figure 1. Europe Transdermal Drug Delivery System Market Segmentation, By Country
  • Figure 2. Europe Transdermal Drug Delivery System Market: Key Industry Dynamics
  • Figure 3. Europe Transdermal Drug Delivery System Market: Impact Analysis of Drivers and Restraints
  • Figure 4. Europe Transdermal Drug Delivery System Market Revenue (US$ Mn), 2020 - 2030
  • Figure 5. Europe Transdermal Drug Delivery System Market Revenue Share, by Type 2022 & 2030 (%)
  • Figure 6. Transdermal Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 7. Drug-in-Adhesive Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Matrix Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Reservoir Membrane Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Vapor Patches: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Transdermal Gels: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. Transdermal Sprays: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Europe Transdermal Drug Delivery System Market Revenue Share, by Application 2022 & 2030 (%)
  • Figure 15. Cardiovascular Diseases: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Central Nervous System Disorders: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Pain Management: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Non-Opioid: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Hormonal Applications: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. Transdermal Estrogen & Progesterone Therapy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Testosterone Replacement: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Other Application: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Europe Transdermal Drug Delivery System Market Revenue Share, by Distribution Channel 2022 & 2030 (%)
  • Figure 25. Hospital Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 26. Retail Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 27. Online Pharmacies: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 28. Others: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 29. Europe Transdermal Drug Delivery System Market, by Key Country - Revenue (2022) (US$ Million)
  • Figure 30. Europe Transdermal Drug Delivery System Market, by Country, 2022 & 2030 (%)
  • Figure 31. Germany: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 32. France: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 33. UK: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 34. Italy: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 35. Spain: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 36. Rest of Europe: Europe Transdermal Drug Delivery System Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 37. Growth Strategies in the Transdermal Drug Delivery System Market